Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Parkinson’s Disease | Unmet Need | Adjunctive Therapies for Motor Response Fluctuations | US/EU | 2017
Although motor fluctuations in Parkinson’s disease (PD) can be managed effectively in the early stages of the disease, today’s treatment paradigm is suboptimal owing to the considerable pill…
Postherpetic Neuralgia | Treatment Algorithms | Claims Data Analysis | US | 2017
Postherpetic Neuralgia (PHN) is an inflammatory neuropathic pain condition characterized by pain persisting for more than 30 days after the onset of the herpes zoster rash caused by a byproduct of…
Malignant Melanoma | Unmet Need | BRAF-mutation-positive Unresectable or Metastatic | US/EU | 2017
Treatment of BRAF-mutation-positive unresectable or metastatic malignant melanoma has been transformed in recent years by the identification of BRAFmutations and the development of BRAF and MEK…
Acute Lymphoblastic Leukemia | Niche & Rare Disease Landscape & Forecast | US/EU5 | 2017
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells. Over the last few years, a number of agents have been launched that have improved treatment outcomes for patients with ALL…
Unipolar Depression | Treatment Algorithms: Claims Data Analysis | Major Depressive Disorder | US | 2017
MARKET OUTLOOK MDD is a highly drug-treated condition that utilizes an array of drug classes, including, but not limited to, SSRI , SNRI s, and—as adjunctive therapies—atypical…
